INTRODUCTION
============

The family of multichain immunorecognition receptors (MIRRs), including the high-affinity immunoglobulin E (IgE) receptor (FcεRI), the B-cell receptor (BCR), and the T-cell receptor (TCR), trigger a wide array of signaling outcomes critical for immune cell function, including cell survival, release of inflammatory mediators, and cytokine production. A distinguishing feature of the MIRRs is their lack of intrinsic kinase activity, rendering them reliant on the recruitment and activation of nonreceptor tyrosine kinases for signaling ([@B63]). For FcεRI and BCR, antigen engagement results in phosphorylation of accessory chain immunoreceptor tyrosine--based activation motifs (ITAMs) ([@B30]) by the Src family kinases Lyn and Fyn, followed by the recruitment and activation of the tyrosine kinase Syk. The parallel signaling cascade of the TCR relies on sequential engagement of the Src family kinase Lck and the Syk-related kinase Zap70.

As the only two members of a kinase subfamily, Syk and Zap70 share structural similarities that regulate kinase activity through conformational state changes. Key features include tandem SH2 domains that are joined via a linker (interdomain A \[I-A\]), and a kinase domain (KD) connected via a second linker region (interdomain B \[I-B\]) ([@B3]). Interactions between the linker domains and the kinase domain create an autoinhibited conformation ([@B16]); this closed state is likely the predominant conformation of Syk/Zap70 in a resting cell. Transitions to an open conformation facilitate binding of the tandem SH2 domains to dually phosphorylated ITAMs and free the kinase domain for activity ([@B30]). The ITAM-docked open conformation also exposes a number of autophosphorylation sites, as well as tyrosines that are substrates for Src kinases ([@B56]; [@B2]; [@B20]; [@B9]). Phosphorylation of Syk at these sites promotes kinase activation ([@B72]) and provides docking sites for distinct downstream signaling molecules ([@B64]). Phosphotyrosines are also implicated in structural modifications of Syk. For example, phosphorylation of I-B tyrosine residues in both Syk and Zap70 favors the open state ([@B6]), and recent studies have shown that phosphorylation of these residues in Zap70 is associated with longer dwell times on the TCR ([@B33]). Phosphorylation of key residues in the catalytic domain of Syk also enhances enzymatic activity ([@B8]). It is important to note that, despite their similarity, these two closely related kinases also have important distinctions. Notably, Zap70 activation by the TCR is reliant on the Src family kinase Lck, as well as the protein phosphatase CD45, whereas Syk can reconstitute TCR signaling without these two players ([@B10]). Reliable and quantitative measures that capture receptor--­kinase interaction dynamics are needed to understand the full range of mechanisms underlying the similarities and differences between these essential immune kinases ([@B73]; [@B48]).

This work focuses on the dynamics of Syk recruitment to FcεRI following aggregation of the receptor by multivalent antigen. Immunoelectron microscopy studies have shown that FcεRI cross-linking leads to a dramatic increase in the amount of Syk associated with the receptor at the plasma membrane ([@B80]). However, FcεRI aggregates can vary in size and mobility as a function of antigen dose or valency ([@B1]; [@B39]). Therefore, establishing the relationship between receptor aggregate size and signaling efficiency is of keen interest ([@B79]). Mathematical modeling studies have predicted that membrane receptor clustering can lead to enhanced signaling output by promoting multiple rebinding events ([@B14]; [@B54]). On the other hand, membrane topographical features or posttranslational modifications that reduce diffusion-mediated access or dwell time at the ITAM domain could negatively influence signaling. Thus, while structural and biochemical studies have provided information on the sequence of events needed for Syk activation in this signaling cascade, many questions remain concerning the timing and extent of Syk recruitment needed to efficiently propagate signaling. We performed single-particle tracking (SPT) using total internal reflection fluorescence (TIRF) microscopy to quantify the dynamics of Syk recruitment to the membranes of gene-edited RBL-2H3 cells whose endogenous Syk expression was ablated and reconstituted with either wild-type (WT) or mutant Syk expressed as a chimeric mNeonGreen (mNG) fusion protein. Immunological and biochemical assays were used to determine the impact of changes in FcεRI-Syk dynamics on mast cell functional responses.

We find that Syk binding at the mast cell membrane is best described as a mixture of lifetimes characterized by a fast off-rate (*k~f~* = 2.6 s^−1^) and a slow off-rate (*k~s~* = 0.62 s^−1^), indicating a population of both short-lived and long-lived binding events. Aggregation of FcεRI leads to a marked increase in the fraction of trajectories characterized by *k~s~* compared with *k~f~*, and treatment with the Lyn specific inhibitor dasatinib drastically reduces this *k~s~* fraction. These results indicate that *k~s~* characterizes specific recruitment of Syk to phosphorylated FcεRI. Based upon two-color imaging, Syk-FcεRI colocalization is sustained through rapid exchange with the pool of cytosolic Syk. The importance of the longer-lived interactions in signal propagation is shown by introduction of a Y130E mutation within the I-A domain of Syk. Phosphorylation of Y130 is proposed as a form of negative-feedback regulation, because it has been shown to destabilize binding of Syk tandem SH2 domains to phosphorylated ITAMs (pITAMs) ([@B88]; [@B19]). We find that Syk-Y130E is still recruited to FcεRI aggregates, but its interactions are more transient (*k~s~* = 0.87 s^−1^) and markedly less efficient at transphosphorylation. In cells expressing only the Syk-Y130E mutant form of Syk, mast cell degranulation and specific cytokine production (TNFα, IL-3) are impaired but, remarkably, production of MCP-1 and IL-4 is retained.

In previous work it has been shown that the kinetics of ligand--­receptor binding impact signaling events and cellular responses ([@B41]; [@B35]; [@B71]; [@B68]). FcεRI signal transduction therefore has classically been considered to be controlled at the step of receptor aggregation according to the principles of kinetic proofreading ([@B25]). Here we find that propagation of a subset of cellular responses is similarly sensitive to the off-rate of Syk recruited to aggregated receptors. These data highlight the importance of finely tuned protein--protein interactions in directing cellular outcomes.

RESULTS
=======

Syk recruitment to FcεRI is transient
-------------------------------------

We began by generating a Syk knockout subline of RBL-2H3 cells (Syk-KO) through CRISPR-Cas 9--mediated editing. These cells were then reconstituted with WT Syk expressed as an mNG fusion protein (Syk^mNG^). Syk-mediated downstream signaling in these cells was fully rescued, including restoration of degranulation responses downstream of FcεRI aggregation (Supplemental Figure S1). To follow Syk^mNG^ recruitment to activated FcεRI, we next primed cells with fluorescent anti-DNP IgE (Alexa Fluor 647--conjugated IgE \[AF647-IgE\]) and then challenged cells with the multivalent antigen DNP-bovine serum albumin (BSA) (0.1 μg/ml). Confocal images in [Figure 1A](#F1){ref-type="fig"} and Supplemental Video 1 show the expected increase in FcεRI clustering that accompanies 5 min of antigen-simulated aggregation and the formation of signaling patches ([@B80]). Receptor cross-linking also led to the accumulation of Syk^mNG^ at the membrane, where it colocalized with FcεRI aggregates ([Figure 1A](#F1){ref-type="fig"} and Supplemental Video 1). The recruitment of Syk^mNG^ to the plasma membrane was lost in cells pretreated with dasatinib, which selectively inhibits Src and Abl tyrosine kinases ([@B36]) ([Figure 1B](#F1){ref-type="fig"}, TIRF images). Further proof that the observed binding events are specific to FcεRI aggregation is shown in [Figure 1C](#F1){ref-type="fig"}, where the disruption of FcεRI aggregates by monovalent DNP-lysine also results in rapid dissociation of Syk^mNG^ clusters. After the addition of DNP-lysine, single molecules could be resolved near the original cluster before release into the cytosol ([Figure 1C](#F1){ref-type="fig"}, bottom, and Supplemental Video 2). The apparent persistence of Syk at the membrane over this short period may reflect interactions with phosphorylated FcεRI monomers or other membrane components (possibly LAT or other substrates) that persist for a short time after the dissolution of FcεRI aggregates.

![Syk Recruitment to FcεRI. Syk-KO RBL cells expressing Syk^mNG^ (green) were primed with AF647-IgE (magenta) and imaged after cross-linking with 0.1 µg/ml DNP-BSA. (A) Sample images from a confocal time series showing the redistribution of AF647-IgE-FcεRI and Syk^mNG^ upon FcεRI stimulation (see also Supplemental Video 1). Resting cross-section shows homogeneous distribution of AF647-IgE-FcεRI at the plasma membrane and Syk^mNG^ in the cytosol. Upon cross-linking (5 min), FcεRI aggregation and Syk^mNG^ colocalization is readily seen at the adherent cell surface. Scale bar: 10.3 µm. White boxes in the "Overlay" panels are enlarged in the "Zoom" panels. Scale bar: 2 µm. (B) Treatment with 1 µM dasatinib results in a loss of Syk^mNG^ recruitment (bottom) to FcεRI aggregates (top). Images of the adherent cell membrane acquired in TIRF. Scale bar: 5 µm. (C) Both FcεRI and Syk^mNG^ aggregates (top) are disrupted upon addition of 100 mM monovalent DNP-lysine (middle). Scale bar: 5 µm. Selected images from a time series (bottom) show the dispersion of an individual Syk aggregate within seconds of DNP-lysine addition. Individual Syk^mNG^ molecules can be seen diffusing away from the original diffraction-limited aggregate (see also Supplemental Video 2). Images acquired in TIRF. Scale bar: 1 µm. (D) Plot of positive correlation between Syk^mNG^ and AF647-IgE intensity within each AF647-IgE aggregate. (E) Selected images from a confocal time series before and after photobleaching (at *t* = 0 s) of an individual Syk^mNG^ aggregate. Scale bar: 1 µm. Bottom curve quantifies the rapid recovery of mNG fluorescence intensity within the bleached region (white circles).](3397fig1){#F1}

We next examined the recruitment capacity of FcεRI aggregates by comparing receptor aggregate size and density with Syk^mNG^ accumulation. Using two-color TIRF imaging, AF647-IgE images were first segmented by creating an intensity mask to identify individual receptor aggregates, from which corresponding AF647-IgE and Syk^mNG^ intensities were determined. The linear correlation of the IgE-FcεRI and Syk^mNG^ intensities per aggregate seen in [Figure 1D](#F1){ref-type="fig"} indicates that, as receptor aggregates increase in size, more Syk^mNG^ is recruited. Finally, we assessed the dynamics of FcεRI-Syk interactions using fluorescence recovery after photobleaching (FRAP). Syk^mNG^ colocalized with FcεRI aggregates demonstrated rapid fluorescence recovery within 20 s ([Figure 1E](#F1){ref-type="fig"}), while the FcεRI did not (unpublished data). These results reveal that the observed Syk^mNG^ aggregation is not stable in time but is actually an accumulation of many transient binding events.

Direct measurements of Syk binding dynamics
-------------------------------------------

To directly measure the off-rate of Syk binding, we applied single-molecule imaging to visualize thousands of Syk^mNG^ binding events in living cells. Using TIRF microscopy, we were able to observe and track single Syk^mNG^ molecules as they associated with the adherent surface of the plasma membrane (Supplemental Video 3). We selected our imaging frame rate (100-ms exposure time) to minimize the contribution of fast-moving Syk^mNG^ molecules in the cytosol and selectively capture those Syk^mNG^ proteins that reduce mobility when bound to the membrane ([Figure 2A](#F2){ref-type="fig"}, left). In this scenario, the track length of individual Syk^mNG^ proteins reflects the binding lifetime ([Figure 2A](#F2){ref-type="fig"}, right). As shown in the cumulative probability plots in [Figure 2B](#F2){ref-type="fig"}, we found that the distribution of track lengths shifted to longer duration after FcεRI activation. To extract the underlying Syk off-rates (*k*), we fitted the distribution of track lengths, assuming an exponential binding process, and compared fits across different models (see *Materials and Methods* for details). We found the simplest model consistent with the data was a two-component model with a fast off-rate (*k~f~*) of ∼2.6 s^−1^ and a slower off-rate (*k~s~*) of ∼0.62 s^−1^ ([Figure 2C](#F2){ref-type="fig"}).

![Quantifying FcεRI-Syk interactions using single-particle tracking of Syk^mNG^. Single Syk^mNG^ molecules were tracked using TIRF microscopy as they bound and dissociated from the membrane. (A) Example of Syk^mNG^ trajectories detected at the plasma membrane (left). Projection of trajectories in the time dimension (middle) shows the trajectory lengths. Enlargement of a single trajectory that lasts ∼10 s (right). (B) Cumulative probability distribution of Syk^mNG^ trajectory lengths before (black) and 4--5 min after addition of 1 µg/ml DNP-BSA (green). Solid gray lines represent the fit to the data. (C) Bar graph depicts fast and slow off-rates found when fitting the distributions in B. See *Materials and Methods* for details. (D) Fraction of the slow off-rate component (α~s~) increases from ∼5% to 23% after addition of 1 µg/ml DNP-BSA. Treatment with 1 µM dasatinib (Das) reduces α~s~ in both resting and activated cells. Error bars in C and D are a 68% credible interval as described in *Materials and Methods*. See also Supplemental Table S1.](3397fig2){#F2}

We interpret the faster off-rate to represent nonproductive binding events and the slow off-rate to characterize the specific Syk docking events that correlate with FcεRI signaling. Consistent with this interpretation, we found that the *k~s~* fraction markedly increased from 5% to 23% upon FcεRI activation ([Figure 2D](#F2){ref-type="fig"}). The increase in the *k~s~* fraction with stimulation is blocked when cells are pretreated with the Src family kinase inhibitor dasatinib ([Figure 2D](#F2){ref-type="fig"}). These results indicate that the longer-lived events are specifically associated with Syk binding to FcεRI pITAM. Of note, we found that there was a significant population (5%) of *k~s~* Syk^mNG^ binding events in resting cells, which was essentially ablated (\<2%) with dasatinib treatment. This suggests that some basal phosphorylation of FcεRI occurs in the absence of cross-linking to recruit Syk, although we cannot fully exclude the possibility of specific Syk binding to other Src (or Abl) substrates at the membrane. We also found that dasatinib treatment consistently resulted in a reduction in the total number of Syk^mNG^ tracks captured per resting cell. While this was a qualitative observation, it can be interpreted in the context that 95% of observed tracks in resting cells are the fast component. This indicates that a large fraction of the observed tracks for Syk reflect true membrane-binding events. It is well known that low rates of ITAM phosphorylation constitutively occur in immune cells, a phenomenon that is rapidly reversed by phosphatase activity ([@B69]). We conclude that some of the fast tracks observed may be due to nonspecific membrane encounters of cytosolic Syk^mNG^, as we observed for a cytosolic reporter (mNG-PLY; see *Materials and Methods*). The remaining events likely represent true engagements of Syk-SH2 domains as they sample monophosphorylated ITAMs ([@B49]; [@B84]; [@B47]) or other substrates for Src kinases in the membrane ([@B50]). These short-lived encounters are insufficient for signaling, because the increase in the fraction of slow off-rate events is the critical measure that correlates with FcεRI signal propagation.

FcεRI-Syk interaction dynamics are independent of antigen dose or aggregate size
--------------------------------------------------------------------------------

The extent and time course of FcεRI aggregation are features of antigen dose and valency ([@B1]). To establish the aggregation profile of FcεRI after cross-linking with DNP-BSA, we used direct stochastic optical reconstruction microscopy (dSTORM) ([@B75]) superresolution imaging. Imaging was performed in TIRF, which specifically evaluates antigen-mediated aggregation at the adherent membrane surface. [Figure 3, A and B](#F3){ref-type="fig"}, shows the clustering of AF647-IgE--bound receptors after 5 min of treatment over a range of DNP-BSA doses (0.001--1 μg/ml). The comparison in [Figure 3A](#F3){ref-type="fig"}, between the diffraction-limited images at the left and the dSTORM images at the right, illustrates that the ∼10-nm localization accuracy of this superresolution method enables the visualization and quantification ([Figure 3B](#F3){ref-type="fig"}) of aggregation across the full dose--response range. Aggregation is observed even at the lowest doses (0.001 and 0.01 μg/ml), where changes in the diffraction-limited image are not readily discernible.

![FcεRI-Syk off-rate is independent of antigen dose or aggregate size. (A) AF647-IgE--labeled RBL cells cross-linked for 5 min with indicated DNP-BSA concentration and imaged (left) at the adherent surface in TIRF (scale bar: 5 µm) and using (right) dSTORM (scale bar: 2 µm). (B) Clustering of localizations in dSTORM images from A using a hierarchical clustering algorithm (Matlab, MathWorks). Cluster sizes are shown as gray dots, and the distribution is summarized by the mean (red cross), the median (red line), and the 25th and 75th percentiles (blue box). Kolmogorov-Smirnov tests show significant (*p* \< 0.01) differences between resting (0 ng) and other DNP-BSA doses. (C) Mobility of Syk^mNG^ represented as the cumulative distribution of squared displacements (*r*^2^, ΔT = 0.3 s or 3 frames) for each DNP-BSA dose. See Supplemental Table S1 for values. (D) Cumulative distribution of Syk^mNG^ track lengths for each DNP-BSA dose. (E) The fraction of the slow off-rate component (α~s~) increases with DNP-BSA dose. Data collected between 1 and 5 min after the addition of DNP-BSA. Error bars are a 68% credible interval as described in *Materials and Methods*. See also Supplemental Table S1. (F) Comparison of Syk^mNG^ trajectory localization with AF647-IgE aggregates in cells stimulated with 0.1 µg/ml DNP-BSA for up to 5 min. Left, overlay of Syk^mNG^ trajectories (green lines) with AF647-IgE aggregates (magenta). Scale bar: 1 µm. See also Supplemental Video 4. Middle, comparison of Syk^mNG^ track-length distributions inside and outside the AF647-IgE mask. A Kolmogorov-Smirnov test shows the distributions are significantly different (*p* \< 0.01). Right, no correlation is observed between Syk^mNG^ track length and the intensity of the corresponding AF647-IgE aggregate.](3397fig3){#F3}

We showed previously that FcεRI aggregates become essentially immobile at the highest antigen doses (≥0.1 μg/ml) ([@B1]). Because both small (mobile) and large (immobile) complexes were shown to be signaling competent ([@B1]; [@B61]), it was important to determine whether there was a dependence of Syk recruitment on the cross-linking conditions. We found that the mobility of Syk^mNG^ recruited to the membrane is reduced as antigen dose increases ([Figure 3C](#F3){ref-type="fig"} and Supplemental Table S1), following the same trend as the antigen-induced changes in FcεRI mobility (Andrews *et al.*, 2009). [Figure 3D](#F3){ref-type="fig"} shows that the distribution of track lengths shifted toward longer duration as a function of antigen dose. Fitting these distributions across the dose response again supported a model in which the rate constants remain unchanged; rather, it is the fraction of long-lived tracks (α*~s~*) that increases with the concentration of antigen ([Figure 3E](#F3){ref-type="fig"} and Supplemental Table S1). These data suggested that the interaction lifetime of Syk at the membrane is independent of the mobility of receptor aggregates or their cluster size.

To confirm this conclusion, we used two-color imaging to simultaneously correlate receptor aggregate size with Syk^mNG^ dwell times ([Figure 3F](#F3){ref-type="fig"} and Supplemental Video 4). We chose an intermediate dose of DNP-BSA concentration (0.1 μg/ml), for which a range of AF647-IgE-FcεRI aggregate sizes can be seen on the cell surface ([Figure 3, A and B](#F3){ref-type="fig"}). For each Syk trajectory, we compared its track length with the total intensity of the corresponding AF647-IgE-FcεRI aggregate to which it colocalized ([Figure 3F](#F3){ref-type="fig"}). Comparison of Syk^mNG^ dwell times inside and outside the aggregates showed that most long-lived events are associated with FcεRI aggregates ([Figure 3F](#F3){ref-type="fig"}, middle). No correlation between aggregate intensity (i.e., size) and Syk^mNG^ dwell time was found ([Figure 3F](#F3){ref-type="fig"}, right). Thus, signaling is associated with an increase in the number of long-lived Syk binding events rather than changes in binding lifetime.

Phosphomimetic mutation at Y130 increases the Syk off-rate
----------------------------------------------------------

Considering the observation that FcεRI-Syk interaction kinetics are consistent across all DNP-BSA cross-linking conditions, we next sought to experimentally alter the lifetime of Syk on FcεRI pITAMs by introducing mutations in Y130 in the Syk I-A domain. Located between the two tandem SH2 domains, Y130 phosphorylation reportedly lowers the affinity of Syk for pITAMs ([@B28]; [@B88]). We reconstituted Syk-KO cells with mNG-tagged versions of two previously described Syk mutants ([@B28]) (Supplemental Figure S2A): 1) Y130E, a phosphomimetic mutation (Syk^mNG^-Y130E); and 2) Y130F, which cannot become phosphorylated (Syk^mNG^-Y130F). These mutants were also introduced into parental RBL-2H3 cells (Supplemental Figure S2A). As shown in [Figure 4A](#F4){ref-type="fig"}, each of the reconstituted Syk-KO cell lines showed robust membrane accumulation of Syk^mNG^ after stimulation (0.1 μg/ml DNP-BSA) that colocalized with AF647-IgE-FcεRI aggregates. Quantification of these images, shown in [Figure 4B](#F4){ref-type="fig"}, was performed in the same manner as [Figure 1D](#F1){ref-type="fig"}. The Y130E and Y130F mutants of Syk^mNG^ were recruited to FcεRI to a similar extent as WT Syk^mNG^. Thus, despite poor recovery of the Y130E mutant in coimmunoprecipitation studies with the BCR ([@B28]; [@B88]), association of Syk^mNG^-Y130E with FcεRI aggregates is not grossly impaired.

![Syk^mNG^-Y130E exhibits a faster FcεRI off-rate. (A) TIRF images of AF647-IgE (magenta) and Syk^mNG^ (green) membrane localization in Syk-KO cells reconstituted with Syk^mNG^-WT (left), Syk^mNG^-Y130E (middle), or Syk^mNG^-Y130F (right) after 4--5 min stimulation with 0.1 µg/ml DNP-BSA. Scale bar: 5 µm. (B) Quantification of FcεRI recruitment capacity for Syk. Individual aggregates of AF647-IgE were masked, and the total intensity within the mask for both the AF647-IgE and Syk^mNG^ channels is plotted per aggregate. Recruitment is similar for Syk^mNG^-WT and each mutant. (C) Cumulative probability distributions of trajectory lengths for Syk^mNG^-WT, Syk^mNG^-Y130E, and Syk^mNG^-Y130F both before (dashed lines) and after (solid lines) addition of 1 µg/ml DNP-BSA. (D) Bar graph depicts the slow off-rate (*k~s~*) found when fitting the distributions in C. Fraction of slow off-rate component (α~s~) increases with DNP-BSA dose for Syk^mNG^-WT and each mutant (right). Error bars are a 68% credible interval (see *Materials and Methods*).](3397fig4){#F4}

We next considered whether these mutations could alter the interaction dynamics of Syk at the membrane. Using the Syk^mNG^-Y130E and Syk^mNG^-Y130F stable cells lines, we used TIRF microscopy to image single Syk^mNG^ binding events for both mutant forms of Syk. In the resting state, both the Y130E and Y130F mutants have a similar track-length distribution to that of WT (Syk^mNG^-WT) ([Figure 4C](#F4){ref-type="fig"}, dashed lines). Interesting differences were observed, however, upon activation with DNP-BSA. Although Syk^mNG^-WT and Syk^mNG^-Y130F showed the expected increase in track-length distribution with FcεRI activation, track lengths of Syk^mNG^-Y130E did not shift to the same extent. These distributions were best fitted to a two-component model with a modified off-rate, *k~s~*, for Y130E mutants of 0.87 s^−1^, compared with 0.62 s^−1^ for Syk^mNG^-WT and 0.65 s^−1^ for Syk^mNG^-Y130F ([Figure 4D](#F4){ref-type="fig"} and Supplemental Table S1). An increased off-rate for Syk^mNG^-Y130E was also observed in cells expressing endogenous Syk (Supplemental Figure S3, A and B). The fraction of *k~s~* for all three Syk isoforms exhibited a similar increase as a function of DNP-BSA dose ([Figure 4D](#F4){ref-type="fig"}, right), consistent with the idea that higher antigen doses are associated with an increase in the number of long-lived Syk binding events.

Mast cell responses are sensitive to Syk lifetime on FcεRI
----------------------------------------------------------

Mast cells are known to release histamine and other granule contents within minutes of FcεRI stimulation, followed by transcriptional up-regulation of cytokine and chemokine production ([@B43]). To explore whether the subtle dynamic changes we observed for the Syk-Y130E off-rate have functional consequences, we evaluated the impact on FcεRI-mediated release of inflammatory mediators. Syk-KO cells reconstituted with either Syk^mNG^-WT or Syk^mNG^-Y130F have comparable degranulation responses to antigen stimulation ([Figure 5A](#F5){ref-type="fig"} and Supplemental Figure S1). In contrast, cells reconstituted with Syk^mNG^-Y130E were incapable of secreting preformed mediators under the same stimulating conditions ([Figure 5A](#F5){ref-type="fig"} and Supplemental Figure S1). To ensure that Syk^mNG^-Y130E reconstituted cells were competent for degranulation, we also treated replicate samples with ionomycin (1 μM) plus phorbol 12-myristate 13-­acetate (PMA). Syk-Y130E cells do release granule contents in response to stimuli that bypass the receptor to elevate calcium levels (Supplemental Figure S2B). Additionally, we found that kinase activity in vitro was similar for all three Syk variants (Supplemental Figure S2C); thus impaired degranulation in the Syk^mNG^-Y130E--expressing cells cannot be explained by altered kinase activity.

![Key mast cell outcomes are impaired in Syk^mNG^-Y130E cells. (A) Degranulation measured by relative β-hexosaminidase released after 30 min of incubation with 0.1 µg/ml DNP-BSA in Syk-KO cells reconstituted with Syk^mNG^-WT, Syk^mNG^-Y130E, or Syk^mNG^-Y130F. (B) Comparison of cytokine concentration in cell media of Syk-KO cells reconstituted with Syk^mNG^-WT, Syk^mNG^-Y130E, or Syk^mNG^-Y130F before and after 3-h stimulation with 0.1 µg/ml DNP-BSA. Results were repeated at least three times for all four cytokines. Bar plots represent mean and SD of technical replicates in one representative sample preparation. (C) The formation of actin plaques at the basolateral surface (left) and ruffling on the apical surface (right) in response to 0.1 µg/ml DNP-BSA treatment in both Syk^mNG^-WT and Syk^mNG^-Y130E reconstituted Syk-KO cells. Filamentous actin labeled with phalloidin-AF647 (red). Scale bar: 2 µm. (D, E) Heat maps of relative changes in intracellular calcium concentration upon either addition of a (D) low dose (0.001 µg/ml) or (E) high dose (1 µg/ml) of DNP-BSA. Each row represents the ratio of Fura-2 emission using 350-nm/380-nm excitation for a single cell over time. Ratio color bar scale range, one- to twofold increase: blue--red. (F) Relative increase in Fura-2 ratio per cell after addition. (G) Time between antigen addition and response for each cell. (F,G) Stimulated with 1 µg/ml DNP-BSA and calculated as described in *Materials and Methods*.](3397fig5){#F5}

We also evaluated release of newly formed mediators from each of the three Syk-reconstituted cell lines during 3 h of stimulation with 0.1 μg/ml DNP-BSA, including the cytokines IL-3, TNFα, and IL-4 and the chemokine MCP-1 (CCL2). In Syk^mNG^-WT-- and Syk^mNG^-Y130F reconstituted cells, antigen stimulation led to production of all four factors ([Figure 5B](#F5){ref-type="fig"}). Syk^mNG^-Y130E cells, on the other hand, completely lost the ability to produce TNFα and IL-3, while production of MCP-1 was normal or somewhat attenuated compared with WT or Y130F-expressing cells. IL-4 production in Syk^mNG^-Y130E cells was variable, but detectable in two of four samples.

FcεRI activation is also known to induce phosphoinositide 3-kinase (PI3K)-dependent ventral cell ruffling and dorsal actin plaque formation ([@B52]; [@B4]). [Figure 5C](#F5){ref-type="fig"} shows that these responses are comparable in Syk-KO cells reconstituted with either Syk^mNG^-WT or the Syk^mNG^-Y130E mutant. Because PI3K-mediated production of phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P~3~) allosterically enhances phospholipase C (PLC)-γ activity in this system ([@B5]; [@B65]), we next performed ratiometric imaging of calcium signaling in Fura-2--loaded single cells. Heat maps in [Figure 5](#F5){ref-type="fig"}, D and E, report the composite profiles of calcium responses in at least 30 cells per condition following the addition of antigen. Stimulation with low antigen dose (0.001 μg/ml DNP~24~-BSA) induced measurable calcium responses in Syk^mNG^-WT (33 out of 71 cells) or Syk^mNG^-Y130F (37 out of 72 cells) reconstituted cells, consistent with previous observations. By comparison, Syk^mNG^Y130E expressing cells were markedly impaired, with only ∼10% (eight out of 84 cells) demonstrating any measurable calcium response to low antigen dose. Notably, Syk^mNG^-Y130E--expressing cells were capable of initiating a calcium response after challenge with high antigen dose (1 μg/ml), as shown in [Figure 5E](#F5){ref-type="fig"}. However, while the amplitude of the calcium response was similar between the three cell types at high antigen dose ([Figure 5F](#F5){ref-type="fig"}), the onset of calcium flux was delayed by ∼20 s in the Syk-Y130E--expressing cells ([Figure 5G](#F5){ref-type="fig"}).

Syk phosphorylation kinetics are finely tuned to ITAM interaction times
-----------------------------------------------------------------------

Syk-Y130E strikingly failed to support a number of key mast cell outcomes (degranulation and TNFα and IL-3 release), whereas other responses downstream of FcεRI activation were unaffected (MCP-1 production, ruffling). This suggests that the reduced interaction times observed for Syk-Y130E correlate with differences in phosphorylation linked to specific arms of the FcεRI signaling network. Western blot analysis was performed to compare the extent of phosphorylation at four critical tyrosine residues (Y317, Y342, Y346, Y519/520) within WT and mutant Syk^mNG^ after 5 min of stimulation with 0.1 μg/ml DNP-BSA ([Figure 6A](#F6){ref-type="fig"}). Both Syk^mNG^-WT and Syk^mNG^-Y130F were strongly phosphorylated at all four tyrosine sites in response to antigen, while Syk^mNG^-Y130E demonstrated a varied phosphorylation profile. Two of the sites in the I-B linker region (Y317, Y346) are known substrates of Lyn ([@B32]; [@B57]), although they can also be *trans*-phosphorylated by adjacent Syk molecules ([@B72]). The other two sites (Y519/520 and Y342) are critical Syk autophosphorylation sites. In cells reconstituted with Syk^mNG^-Y130E, phosphorylation at Y317 and Y346 was unimpaired, while phosphorylation of Y519/520 and Y342 was markedly inhibited: we observed a twofold reduction in phosphorylation at Y519/520 and a fivefold reduction in phosphorylation at Y342 ([Figure 6A](#F6){ref-type="fig"}, right). This altered Syk^mNG^-Y130E phosphorylation was also observed in parental RBL-2H3 cells expressing these constructs (Supplemental Figure S3C), demonstrating that the presence of endogenous WT Syk cannot rescue Syk^mNG^-Y130E phosphorylation at these two sites.

![Phosphorylation kinetics of Syk and downstream signaling partners. (A) Western blot detection of the Syk phosphorylation profile in Syk-KO cells reconstituted with Syk^mNG^-WT, Syk^mNG^-Y130E, or Syk^mNG^-Y130F in response to stimulation with 0.1 µg/ml DNP-BSA for 5 min. Bar plots (right) represent mean and SD of relative Syk phosphorylation level from at least three experiments. Phosphorylation of tyrosines associated with Syk autocatalytic activity (pY519/520 and pY342) is significantly reduced (*t* test: \*, *p* \< 0.05; \*\*, *p* \< 0.01) in Syk^mNG^-Y130E. No significant difference (n.s) in phosphorylation is seen at sites susceptible to Lyn catalytic activity (pY317, pY346). (B) Western blot detection of the phosphorylation time course of downstream signaling molecules Vav1, LAT, and ERK. Cells were stimulated with 0.1 µg/ml DNP-BSA for 0, 2, or 5 min. Bar plots (right) represent mean and SD of the relative phosphorylation levels from three experiments (*t* test: \*, *p* \< 0.05).](3397fig6){#F6}

Decreased phosphorylation at specific Syk autophosphorylation sites is predicted to impair docking of Syk binding partners and/or inhibit their Syk-mediated activation by phosphorylation. [Figure 6B](#F6){ref-type="fig"} reports changes in tyrosine phosphorylation profiles for two Syk substrates downstream of FcεRI activation: LAT ([@B81]) and Vav1 ([@B40]). We also evaluated phosphorylation of ERK as a readout of the Ras-MAPK pathway ([@B22]). In cells expressing Syk^mNG^-WT, LAT phosphorylation peaked at 5 min after stimulation with 0.1 μg/ml DNP~24~-BSA. The onset of LAT phosphorylation was consistently faster in cells reconstituted with Syk^mNG^-Y130F (*n* = 3), peaking at 2 min rather than 5 min, suggesting that this mutant is equal to (or slightly better than) Syk^mNG^-WT at coupling with LAT. In contrast, LAT phosphorylation was delayed in Syk^mNG^-Y130E and reached only 50% of Syk^mNG^-WT levels by 5 min. We also found that antigen-stimulated Syk^mNG^-Y130E cells had an ∼50% reduction in Vav1 phosphorylation compared with Syk^mNG^-WT cells, consistent with prior work identifying Syk pY342 as a key docking site for Vav1 ([@B15]). Finally, phosphorylation of ERK under these conditions was also reduced in Syk^mNG^-Y130E--­expressing cells compared with cells reconstituted with either Syk^mNG^-WT or Syk^mNG^-Y130F. Taken together, these results illustrate that the reduced residency time for Syk^mNG^-Y130E translates to impaired autophosphorylation and impaired coupling to at least three downstream signaling branches.

DISCUSSION
==========

Signaling networks are composed of a series of reactions bifurcating from ligand-bound receptors. The importance of key elements, including cellular colocalization of critical players and detailed biochemical reaction schemes, has laid the foundation for our modern understanding of signal transduction. Although these reactions are often depicted as a linear chain of events, the dynamic interplay of signaling partners and the rapid turnover of posttranslational modifications and/or second messengers are critical components necessary to create a highly sensitive system. Studies of the high-affinity IgE receptor (FcεRI) have contributed significantly to our understanding of the spatiotemporal aspects of cell signaling, due in part to the unique architecture of the signaling complexes formed after antigen-mediated cross-linking ([@B42]). At the onset of signaling, encounters between IgE-bound FcεRI monomers on membranes are diffusion mediated ([@B42]; [@B1]), and the resulting aggregates are influenced by the valency, affinity, and dose of ligand. Because none of the subunits in the FcεRI αβγ~2~ tetramer bears intrinsic catalytic activity, propagation of signals is dependent on sequential recruitment of extrinsic kinases. The dually acylated Src family kinase Lyn is responsible for rapid ITAM phosphorylation ([@B17]). Prior work has suggested that a fraction of Lyn is colocalized with FcεRI clusters in resting RBL-2H3 cells ([@B80]; [@B77]), and a small fraction may be prebound to the FcεRI β-subunit ([@B83]; [@B78]). ITAM phosphorylation supports recruitment of the dual SH2-containing Syk tyrosine kinase from the cytosol ([@B26]; [@B62]).

With the knowledge that Syk translocation is essential for the release of inflammatory mediators from mast cells and basophils ([@B13]; [@B87]), we monitored the dynamics of individual Syk molecules during recruitment to FcεRI in live cells. Recent studies have demonstrated the power of single-molecule imaging methods in capturing the real-time interactions of membrane components with cytosolic binding partners, including clathrin assembly ([@B11]), the TCR's recruitment of Zap70 ([@B46]), and Grb2 association with epidermal growth factor receptor (EGFR) ([@B27]). These works have illustrated the inherent stochastic nature of binding events at the single-molecule level, as well as the highly transient nature of protein interactions during active signaling and trafficking. Our SPT studies of Syk show that interactions with phosphorylated receptors are transient. We used the Syk trajectory lengths to extract a characteristic off-rate for the interaction of Syk at the membrane. From our fitting, we found that the distribution of Syk trajectories was best characterized by a mixture of two rate constants, a nonspecific, fast off-rate (*k~f~* = 2.6 s^−1^) and a slow off-rate (*k~s~* = 0.62 s^−1^) that was directly associated with FcεRI phosphorylation. The fraction of this slow off-rate component increased with higher DNP-BSA dose and IgE-FcεRI aggregation and was ablated in dasatinib-treated cells. Model comparison analysis of fits using a globally constrained *k~s~* value across all conditions versus a freely varying *k~s~* value revealed that our data were best fitted to a model in which the *k~s~* value does not vary with antigen dose (only the fraction of trajectories characterized by *k~s~* varies with dose). This suggests that higher antigen doses and larger IgE-FcεRI aggregates do not alter the fundamental Syk-pITAM interaction kinetics but increase the concentration of pITAMs available for Syk binding. Future work using different antigen geometries or affinities will be important to explore whether other local receptor environments influence Syk-pITAM kinetics.

Mathematical models have led to the prediction that membrane receptor clustering can favor multiple rebinding events between receptors and their signaling partners ([@B14]; [@B54]). Given the limitations of frame rate at which our data were acquired, we considered the possibility that rapid rebinding events to receptors in the same complex aggregate might artificially inflate the observed Syk off-rate. However, we found no correlation between track length and size of receptor aggregates. One interpretation is that, in the unique case of Syk, rebinding may be prevented due to the sequence of conformational and posttranslational changes.

ITAM-bearing receptors, such as the TCR, provided early motivation for use of kinetic proofreading models to study the dependence of signal transduction events on ligand--receptor binding kinetics ([@B41]). In its simplest form, kinetic proofreading predicts that high-affinity ligand--receptor bonds enable completion of a series of intermediate steps necessary to generate productive signals. This mechanism imposes constraints on signaling from nonspecific interactions and provides sensitivity to differences in dose and affinity. However, the FcεRI system also provided early evidence that distal events, including cytosolic messengers, might provide an alternative means of kinetic discrimination for the generation of qualitatively different signals ([@B23]; [@B35]). Prior work by others established conditions using low- and high-affinity ligands for cross-linking IgE-FcεRI complexes that achieved similar receptor phosphorylation levels but differential outcomes. For example, degranulation and TNFα secretion were reduced after challenge with low-affinity ligands, while chemokine (specifically MCP-1) production was unaffected or superior ([@B35]; [@B68]). Rivera and colleagues proposed that the signaling differences could be explained, at least in part, by differential recruitment of Src family kinases (Fgr) and the membrane scaffold, LAT2/NTAL ([@B68]). Both groups also reported a reduced phosphorylation of Syk with low-affinity ligand stimulation. We show here that a single point mutation, Y130E, in Syk alters mast cell signaling in ways that are remarkably similar to stimulation with low-affinity ligand ([@B35]; [@B68]). These distinct cellular outcomes have the potential to promote differential regulation of the immune response. In fact, the prior study linked the ability of low-affinity ligand to evoke chemokine secretion in the absence of degranulation to increased inflammatory macrophage recruitment ([@B68]). We used the same high-affinity, high-valency ligand across all our experiments comparing Syk^mNG^-WT and Syk-Y130E cells. Therefore we expect that FcεRI aggregation kinetics and geometry are consistent in our experiments and that recruitment of Src family kinase members is also unaltered. We found that the reduction in Syk-Y130E phosphorylation was site specific. No change in the Lyn-dependent site Y346 ([@B57]) was observed, again consistent with similar levels of Lyn/Src kinase recruitment. However, sites subject to autophosphorylation ([@B57]) were variable: phosphorylation at Y317 was unchanged, Y519/520 was reduced twofold, and Y342 was reduced fivefold. This pattern suggests a hierarchy of phosphorylation events that is sensitive to FcεRI interaction conditions. It also explains, at least in part, the differential signaling outcomes. For example, pY342 has previously been shown to be critical for Syk to interact with and phosphorylate the downstream partner Vav1 ([@B15]; [@B64]), while pY346 is a critical site for recruitment of Cbl ubiquitin ligase, which is implicated in negative regulation of FcεRI signaling ([@B32]; [@B38]).

The correlation between Syk binding lifetime, phosphorylation kinetics, and cellular outcome is consistent with the idea that the timing of interactions is critical to produce a fully modified protein. Previous in vitro experiments measured the binding of recombinant WT and mutant Syk-SH2 domains to dually phosphorylated TCR-ITAM peptides ([@B88]). On the basis of these data, we expected as much as a 10-fold difference in binding lifetime for WT and Syk-Y130E. The difference that we measured in live cells is only 1.4-fold, which could be explained by conformational constraints of the intact Syk protein, spatial aspects of disulfide-linked full-length, dimeric γ-subunits, and/or influence of the lipid bilayer on ITAM accessibility ([@B37]). Because Syk also exhibits distinct affinities for particular ITAM sequences, ranging from 4 to 40 nM ([@B72]), we might expect that the off-rate of Syk binding will vary in other cellular contexts. In vitro experiments have led to the description of Syk as a molecular switch that acts as an "OR" gate, whereby it is an equally active kinase 1) when engaged in ITAM binding in the open conformation *or* 2) when autophosphorylated ([@B72]). However, our data here suggest that the two mechanisms are connected in a tightly controlled sequence. If Syk is bound sufficiently long to FcεRI to progress to a fully autophosphorylated state, it will remain active after dissociation into the cytosol. If the lifetime of ITAM binding is shorter, as with the Y130E mutant, both arms of the "OR" gate would be affected, leading to less efficient signaling. It follows that the lifetime of active, unbound Syk will also have a limited lifetime, because it will be reversed upon encountering a phosphatase. Importantly, our results demonstrate that kinetic discrimination occurs at the level of Syk, where the extent of Syk phosphorylation at specific sites directs the cellular outcome.

We have demonstrated that Syk activation occurs through transient association with FcεRI. Live-cell studies of Zap70 interacting with TCR have shown a transient interaction between kinase and receptor, with a range of dwell times from 0.2 s to tens of seconds ([@B7]; [@B46]; [@B33]; [@B50]). Although our measurements also found Syk binding to be transient, with lifetimes in the range of those reported for Zap70, it is interesting to note several significant differences between these two family members. Lillemeier and colleagues have used FRAP to examine the interaction time of Zap70 with TCR microclusters ([@B33]; [@B31]). They found that I-B domain residues control the rates of transition between open and closed conformations of Zap70 and that Zap70 closed-conformation mutants exhibited shorter TCR microcluster dwell times than WT ([@B33]). This shorter dwell time was associated with reduced phosphorylation of Zap70 by its Src family kinase, Lck ([@B33]). For Syk, we found that shorter dwell times are not associated with impaired Lyn-dependent Syk phosphorylation; instead, Syk-Syk *trans*-phosphorylation is reduced. Recently the same group examined mutations in the Zap70 I-A domain at Y126, the site analogous to Y130 in Syk ([@B31]). They showed that phosphorylation of Y126 promotes an increased exchange rate of Zap70 from the TCR. In contrast to our results with Syk, Zap70-Y126F displayed longer dwell times than WT. Expressing either Zap70-Y126E or Zap70-Y126F mutants resulted in altered TCR signaling. However, Zap70-Y126F showed impaired calcium signaling and reduced LAT and ERK phosphorylation, outcomes that are more similar to Syk-Y130E in mast cells. Therefore, while Syk and Zap70 share many structural and functional similarities, their distinctive characteristics underscore the need to avoid generalizations about their regulation. Another interesting distinction is the role of Syk in nonimmune cells, where the Syk-Y130E substitution is described as a gain-of-function mutation, because it promotes increased adhesion and microtubule dynamics ([@B86]). Clearly, the cellular context must be considered when dissecting the molecular mechanisms that govern protein function.

In summary, single-molecule imaging has allowed us to quantify the transient interactions between FcεRI and Syk that drive mast cell signaling. We found that FcεRI-Syk binding dynamics are invariant with receptor aggregate size or receptor mobility. We also found that small changes in the dynamics of Syk binding, induced by the phosphomimetic mutation Y130E, are associated with significant alterations in the Syk phosphorylation profile and impaired mast cell responses. Taken together, these results support a model consistent with Syk-ITAM interactions that are independent of local receptor density but highly sensitive to interaction time.

MATERIALS AND METHODS
=====================

Antibodies, antigens, and reagents
----------------------------------

All IgE used in this study was H1-DNP-ε-206 IgE, prepared as described previously ([@B89]). DNP-BSA containing ∼15--25 DNP per BSA was purchased from Thermo Fisher Scientific (A23018), and DNP-lysine was purchased from Sigma (Nε-DNP-[l]{.smallcaps}-lysine hydrochloride, D0380). AF647-IgE was generated using NHS-chemistry as previously described ([@B59]), resulting in an average dye to protein ratio of 3:1. Briefly, AF647-NHS ester dye (Thermo Fisher Scientific; A20006) was reacted at a 10:1 ratio with IgE, and excess dye was purified using a PD MidiTrap G-10 Sephadex desalting column (GE Healthcare; 28-9180-11). All references to pY Syk are named according to tyrosine positions in rodent Syk. Antibodies used are listed as follows: horseradish peroxidase--conjugated anti-pY99 and anti-pY20 (Santa Cruz Biotechnology; sc7020, sc508), anti-mouse and anti-rabbit secondary antibodies (Santa Cruz; SC-7020 SC-2004), Syk (Cell Signaling; D3Z1 XPR \#13198), pY-Syk pY342 (Abcam; 195700), pY519/520 (Cell Signaling; C87C1, 2710), pY317 (Abcam; AB63515), pY346 (Cell Signaling; 2701), pY-Vav1 (Abcam; ab47282), Vav1 (Cell Signaling; 2502), LAT (LS- C46104), ERK (Cell Signaling; 137F5), and pY-ERK (Cell Signaling; D13.14.4E). Dasatinib was purchased from Santa Cruz Biotechnology (SC-358114) and diluted in dimethyl sulfoxide before further dilution to ensure solubility. Ionomycin and PMA were from Sigma-Aldrich (I3909, 79326). Fura-2 AM and AF647-phalloidin were from Thermo Fisher Scientific (A22287, F1201).

Genome editing: Syk-KO cell line
--------------------------------

Cas9-mediated DNA cleavage was used to knock out the endogenous gene coding for the Syk protein in RBL-2H3 cells via the insertion of a premature stop codon in the first exon of the gene. A highly specific single guide RNA (gRNA) (5′-GGCCAGAGCCGCAATTACCT-3′) targeting the first exon of rat *Syk* was designed using the <http://crispr.mit.edu> portal and then subcloned into PX458 vector (Addgene plasmid \#48138) for simultaneous expression of the gRNA, WT Cas9, and a green fluorescent protein (GFP) reporter. For the gRNA subcloning, two partially complementary oligonucleotides (Integrated DNA Technologies) were assembled by PCR. Gel-purified PCR products were cloned into *Bbs*I-digested PX458 using Gibson Assembly (NEB) following the manufacturer's specifications. After cloning and sequencing, the final plasmid was used to transiently transfect RBL-2H3 cells using the Amaxa system (Lonza) following the manufacturer's recommendations. Positive, GFP-expressing cells were selected by flow cytometry using an iCyt cell sorter and immediately plated at suboptimal concentration in 96-well plates. Subclones were screened using Western blotting to identify clones with no Syk expression. The absence of residual GFP expression in Syk KO clones was assessed using a Nikon TE2000 epifluorescence microscope.

Constructs
----------

Syk^mNG^-WT, Syk^mNG^-Y130E, and Syk^mNG^-Y130F all refer to murine Syk DNA C-terminally fused to mNG via a short V5 linker (GGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCTACG) tag. The V5 tag was added to mNG (Allele Biotechnology User License) via fusion PCR. Murine Syk cDNA (Thermo Scientific, MMM1013-202858457) fused to V5-mNG was generated by gene fusion PCR ([@B24]) using PfuUltra DNA polymerase (Stratagene). Y130E and Y130F mutations were introduced during gene fusion via primers with the corresponding mutation at codon 130. Total cDNA was amplified by PCR before subcloning into pcDNA3.1 directional topo vector (Life Technologies). All constructs were checked by sequencing.

Cell lines
----------

RBL-2H3 cells ([@B44]; [@B80]) were cultured in MEM supplemented with 10% heat-inactivated fetal bovine serum, puromycin, and [l]{.smallcaps}-glutamine. To ensure authenticity, cells were checked for IgE binding and degranulation response after each thaw and used for up to 10 passages. Transfections were performed using the Amaxa system (Lonza) with Solution L and Program T-20. Stable cell lines were generated through G418 selection over a 1-wk period followed by isolation of positive, mNG-expressing cells using an iCyt cell sorter with a 525/50-nm emission filter. Cell lines were checked for equal expression levels before experiments using an Accuri C6 flow cytometer (FL-1) and sorted again when needed. For all microscopy experiments, cells were plated into eight-well Lab-Tek (Nunc) chambers at a density of 50,000 cell/well, primed overnight with unlabeled or AF647-IgE as indicated, and then imaged within 24 h.

Immunoblotting and immunoprecipitation
--------------------------------------

Cells (3 × 10^6^) were plated on 100-mm tissue-grade culture plates and primed overnight with IgE. Cells were stimulated with 0.1 μg/ml DNP-BSA or mock for indicated time at 37°C in Hank's buffered saline. Cell lysates from each plate were prepared in cold NP-40 lysis buffer. Protein concentration of cleared lysates was measured by bicinchoninic acid assay (Pierce, Rockford, IL), and equal amounts of total protein were separated on a 4--15% polyacrylamide gel (Bio-Rad, Hercules, CA), transferred to nitrocellulose (Life Technologies, iBlot transfer system), probed with the indicated antibody according to the manufacturer's recommendation, and imaged using enhanced chemiluminescence on a Bio-Rad ChemiDoc. For detection of LAT phosphorylation, samples were immunoprecipitated using protein A beads (Amersham GE Healthcare) loaded with anti-LAT primary antibody, then immune complexes were denatured and immunoblotted as described. Band intensities were quantified using the Bio-Rad Image Lab Software (Image Lab, version 4.0.1) automatic band detection or via the volume tool with automatic background adjustment. Phosphorylated band intensity was normalized to total protein, and all bands were adjusted for loading using β-actin.

Kinase activity assay
---------------------

Syk-KO cells stably expressing Syk^mNG^-WT, Syk^mNG^-Y130E, Syk^mNG^-Y130F, or mock were lysed and immunoprecipitated using mNeonGreen nAb Agarose beads (Allele Biotechnology; ABP-NAB-MNGA050) according to the manufacturer's protocol. Kinase activity was assessed as described previously ([@B67]). Syk protein concentration across precipitate samples was semiquantified by SDS--PAGE followed by immunoblotting using an anti-Syk antibody. Blots were incubated, exposed, and quantified as described in the *Immunoblotting and immunoprecipitation* section. Absorbance for Syk^mNG^-WT, Syk^mNG^-Y130E, and Syk^mNG^-Y130F precipitates was normalized by relative protein levels with the absorbance for Syk-KO precipitates used as a baseline offset.

Degranulation
-------------

Cells were grown in 24-well tissue culture plates for 24 h and primed with IgE. Cells were washed and stimulated in Hank's buffer with indicated concentration of DNP-BSA for 30 min at 37°C. Release of granular content was measured by β-hexosaminidase concentration as previously described ([@B59]). For determination of calcium-independent secretion potential, cells were treated with 1 μM ionomycin (Sigma I3909-1mL) and 50 nM PMA (phorbol 12-myristate 13-acetate, Sigma \#P1585-1MG) for 30 min at 37°C.

Calcium imaging and analysis
----------------------------

Measurements were carried out as previously described ([@B59]). The ratio of fluorescence intensity at 350-/380-nm excitation was calculated for each cell over time after background subtraction. Calcium ratio time courses were fitted to a model: where *O* is the prestimulation signal, *t*~0~ is the lag time between stimulation and response, *A* is the maximum rise height, and *a* and *b* describe the rise and decay kinetics, respectively.

Cytokine release measurements
-----------------------------

Cells were primed with IgE and grown in six-well tissue culture plates for 24 h. Cells were washed and stimulated in Hank's buffer with 0.1 μg/ml DNP-BSA for 3 h. Supernatants were collected and mailed for shipment to RayBiotech, according to company protocol. Cytokine quantification was performed in-house by RayBiotech using their custom Rat Biomarker Quantibody platform. Samples were run in triplicate to assess technical variability. Results from at least three separate sample preparations for each cytokine were used to assess repeatability.

Confocal microscopy
-------------------

Cells were primed with AF647-IgE and imaged using a Zeiss LSM800 laser-scanning confocal microscope equipped with a 63× oil objective and both 488- and 640-nm solid-state diode-laser excitation. Cells were imaged in Hank's buffer at 35°C. For FRAP studies, cells were stimulated for more than 3 min with 0.1 μg/ml DNP-BSA. Small regions of interest (ROIs) were identified, and then a bleaching time series was acquired using the Zen2 software bleach ROI tool. For quantification, signal intensity recovery within the bleach regions was compared with signal in nonbleached regions to correct for photobleaching and background offset, then normalized to the prebleach intensity of the region. For actin labeling, cells were stimulated for 4 min with DNP-BSA before fixation with 4% paraformaldehyde (PFA) for 15 min followed by addition of ∼6.6 µM AF647-phalloidin for 30 min.

TIRF microscopy optical setup
-----------------------------

All TIRF imaging data were collected using an inverted microscope (IX71; Olympus) equipped with a 150×/1.45 NA oil-immersion, TIRF objective (U-APO; Olympus). A 637-nm laser diode (HL63133DG; Thorlabs) was used for AF647 excitation, and a 488-nm laser (Cyan Scientific; Spectra-Physics) was used for fluorescence excitation of mNG. A quad-band dichroic and emission filter set (LF405/488/561/635-A; Semrock) was used for sample illumination and emission. Emission light was separated onto different quadrants of an electron-multiplying charge-coupled device (EMCCD) camera (iXon 897; Andor Technologies), using a custom-built two-channel splitter with a 655-nm dichroic (Semrock) and 584/20-nm, 690/20-nm additional emission filters. Images had a pixel size of 0.106 μm and were acquired at 10 frames per second (100-ms exposure time).

Live-cell TIRF microscopy
-------------------------

Samples were imaged in Hank's buffer at 35°C, and temperature was maintained using a Bioptics Objective heater. Images were acquired before, during, and for up to 5 min after addition of DNP-BSA at the indicated concentrations. The 637-nm laser diode excitation was pulsed to limit photobleaching of AF647-IgE; every 10 frames, the laser was cycled on for two frames and then off for eight frames. A 488-nm laser intensity of 0.006 kW/cm^2^ was used for all imaging of single mNG-Syk molecules. If the mNG expression level in a cell of interest was too high, it was photobleached slightly out of TIRF with 0.38 kW/cm^2^ 488-nm laser intensity before image acquisition, meaning a population of dark/bleached Syk-mNG also existed in all images. For dasatinib treatment, cells were incubated with 1 μM dasatinib for 30 min before imaging and also maintained during imaging and stimulation with DNP-BSA. For DNP-lysine addition, cells were prepared and activated as described for 4--5 min, allowing visible AF647-IgE aggregation, followed by addition of DNP-lysine to a final concentration of 100 μM. Cells were imaged continually during this process.

TIRF microscopy channel registration
------------------------------------

Quadrants of the EMCCD camera representing different fluorescence emission channels were aligned as follows. White-light illumination through a channel-alignment grid slide (Miraloma Tech) that contained a 20 × 20 array of 200 ± 50 nm holes at an intrahole distance (nonregular) of 3 ± 1 microns (total size ∼60 × 60 microns) was used to create an estimation of single point emitters appearing in both quadrants at regular samplings across the channel. The intensity passing through the holes was optimized to maximize number of photons without saturation. The localizations within each channel were then used to create a locally weighted transform matrix using the Matlab "fitgeotrans" method with the "lwm" option and the recommended 12 control points ([@B21]).

Image masking
-------------

Intensity masking to quantify and compare the extent of IgE/Syk aggregation was carried out using image-processing functions from Matlab (MathWorks) and the freely available Matlab package DipImage (Delft University of Technology). A whole-cell mask was identified by Gaussian filtering the image (kernel size = 2) and then thresholding using Matlab's "multithresh" function, followed by the DipImage "closing" function. The overall image intensity was corrected for photobleaching by normalizing to the relative change in intensity within the whole-cell mask over time. A two-step image-segmentation process was used to identify aggregates within this cell mask. 1) Images were smoothed and filtered using the DipImage "smooth" and "dcc" functions, then a threshold was identified using the Matlab "multithresh" function and applied to the image, generating a mask representing regions of aggregation within the image. 2) For better isolation of individual aggregates, a watershed transform was applied using the DipImage "watershed" method with connectivity = 1, creating a second mask representing local areas of minimum intensities (watershed lines). The watershed lines from this step were then removed from the aggregate mask found in the first step to generate a final mask. The fluorescence intensity within each isolated mask was measured using the DipImage "label" and "measure" functions. The dynamics of aggregated AF647-IgE are relatively slow, so for analysis purposes, masks and corresponding mask intensities during "laser off" frames between 637-nm laser-excitation pulses (as described in the *Live-cell TIRF microscopy* section) were assumed to be static.

Superresolution imaging
-----------------------

Parental RBL cells labeled overnight with AF647-IgE (as described in the *Cell lines* section) were washed three times with warm Hank's buffer to remove any unbound AF647-IgE; this was followed by stimulation at the indicated concentration of DNP-BSA in Hank's buffer for 5 min at 37°C. Cells were then quickly fixed with 4% PFA, 0.2% gluteraldehyde for 2 h. Cells were extensively washed with phosphate-buffered saline and once with 10 mM Tris-HCl (pH 7.2) for 10 min to quench reactive cross-linkers. Samples were imaged as previously described ([@B76]; [@B74]) using the same optical setup as described in the *TIRF microscopy optical setup* section and 637-nm laser power of ∼1.7 kW/cm^2^. Images were acquired at 57 frames/s in TIRF. Between 10,000 and 20,000 frames were collected for each image reconstruction. The sample chamber was mounted in a three-dimensional piezostage (Nano-LPS; Mad City Labs, Madison, WI) with a resolution along the *x*,*y*,*z*-axes of 0.2 nm. Sample drift was corrected for throughout the imaging procedure using a custom-built stage-stabilization routine.

Superresolution image reconstruction and cluster analysis
---------------------------------------------------------

dSTORM images were analyzed and reconstructed with custom-built MATLAB functions as described previously ([@B76]; [@B85]). Images were reconstructed from between 5 × 10^5^ and 5 × 10^6^ fit positions. To characterize the degree of AF647-IgE-FcεRI aggregation, we used an implementation of Matlab's hierarchical clustering algorithm "linkage()" using the "single" method to group localizations into clusters. Code for this analysis, "Clustering Classes Version 2," along with more information regarding the technique ([@B34]), is available through the University of New Mexico's SpatioTemporal Modeling Center website (<http://stmc.health.unm.edu/tools-and-data>).

Diffusion coefficient estimation
--------------------------------

Trajectories of single Syk^mNG^ (300--3000; see Supplemental Table S1) were used for each indicated concentration of DNP-BSA to calculate a diffusion coefficient using a previously developed maximum-likelihood estimation algorithm ([@B55]). The 95% confidence intervals were calculated using a log-likelihood ratio test (Pawitan, 2001).

Code availability
-----------------

All computer code is available upon request.

Extracting dissociation rates from single-particle tracking of low signal-to-noise data
---------------------------------------------------------------------------------------

As has been nicely summarized previously ([@B46]; [@B82]; [@B53]), successful characterization of binding lifetimes from single-molecule fluorescence data is highly dependent on the ability to 1) minimize photobleaching while maintaining an adequate signal-to-noise ratio, 2) accurately localize single molecules and connect them across frames to build trajectories, and 3) accurately fit the distribution of trajectory lengths (representing the binding duration) to a binding model. Use of the mNG fluorophore ([@B60]) allowed us to tune our laser power such that the rate of photobleaching was over an order of magnitude slower than our observed dissociation rates (Supplemental Figure S4A). The next sections detail our localization, tracking, and off-rate parameter estimation.

Localization intensity--based change point detection and thresholding
---------------------------------------------------------------------

We found that many Syk^mNG^ trajectories represented more than a single molecule within a diffraction-limited area. We used an intensity change point algorithm ([@B18]; [@B46]) to identify changes in intensity over the duration of the trajectory (Supplemental Figure S4B). This algorithm uses a Bayesian model-selection technique to identify discrete changes of mean intensity for sequences of Poisson-distributed data. The only parameter for the model is a Bayes factor used in a recursive decision procedure to divide each trajectory into segments of constant mean intensity. Similar change point profiles were found over a wide range of Bayes factors, but given the experimental variability, we chose a conservative Bayes factor of 2.35 × 10^17^. We also characterized the expected fluorescence for single mNG molecules in TIRF using our experimental setup. Owing to variability in fluorescence illumination and cell membrane morphology, we do not expect the fluorophore intensity to be exactly Poisson distributed. Therefore we chose to experimentally characterize the fluorescence intensity distribution for single-molecule mNG using an mNG fused to an unrelated, artificial pyrabactin resistance--like (PYL) tag (mNG-PYL) (generously provided by Fu-Sen Liang, University of New Mexico) that exhibited significant nonspecific binding at the membrane. On the basis of this empirical intensity distribution, we found \<1% probability that a single mNG has intensity *I*~max~ ≥ 200 photons. *I*~max~ was therefore used as a cutoff to exclude any localizations within our data that were obviously too bright to represent a single mNG. Any trajectories containing more than two localizations above I~max~ were not included in the analysis. We also found the mean fluorescence intensity for all mNG-PYL localizations to be *I*~mean~ = 49.1 photons. This value is consistent with the approximate size of the change point increments found using our change point analysis, even though the analysis does not have any a priori knowledge of the intensity change magnitudes. The trajectory distribution of mNG-PYL was fit to a single exponential with an off-rate of 1.8 s^−1^.

Single-particle tracking method for low signal-to-noise data
------------------------------------------------------------

1\. Segmentation of particle candidates: The segmentation and localization of particle candidates is handled through custom software. Segmentation is performed by identifying potential emitters as the local maxima of a filtered image. We use a filter that convolves the image with the second derivative (Laplacian) of the Gaussian approximation to the microscope point spread function (PSF). Candidate maxima are then thresholded based on their intensity in the filtered image.

Our localization procedure uses a new likelihood-based method. Like other established localization methods, we assume a two-­dimensional pixelated Gaussian PSF model under Poisson noise. Unlike the maximum-likelihood estimation (MLE) approach employed in previous methods ([@B66]), we take a Bayesian approach based on finding the maximum a posteriori (MAP) estimate. The MAP parameter estimator uses a prior probability to regularize the likelihood function, making fast but fallible local-optimization procedures such as the Newton-type methods more robust when used on data from high-speed, low-intensity applications. The MAP estimator uses numerical optimization to find the parameters , such that

Here θ~*x*~ and θ~*y*~ are the emitter's position; θ~*I*~ is the emitter intensity in photons; θ~*b*~ is the mean background signal per pixel in photons; and θ~σ~ is the SD of the apparent Gaussian PSF. The data are the image, **D**, a vector giving the photon counts at each pixel. The likelihood function, *P*(**D** \| θ), under the Poisson noise assumption is described in ([@B66]). Finally, for the prior *P*(θ), we use a diagonal (separable) probability distribution, tuned for the emitter intensity profiles of our experiment: where, for an image of size (*S*~*x*~, *S*~*y*~),

Our maximization procedure for the MAP estimation is performed with custom optimization software that uses a bound-­constrained Newton's method with reflective boundary conditions ([@B12]), and deals with nonnegative-definite Hessians using the modified Cholesky decomposition algorithm of Schnabel and Eskow ([@B58]). For each iteration of the optimization procedure, we compute the objective function value *L*(θ) ([Eq. 1](#m1){ref-type="disp-formula"}), as well as the gradient ∇*L*(θ) and full Hessian matrix ∇^2^*L*(θ). Finally, we evaluate the quality of MAP estimates , by assuring the Hessian is negative-definite at the maxima and the gradient . The observed Fisher information ([@B51]) at the maxima, , then can be used to establish the approximate shape of the posterior distribution *P*(θ \| **D**) in the neighborhood of , allowing accurate error bars on the estimated theta to be established.

Using the observed Fisher information, all emitter candidates that have estimates with a negative information value (which occurs on optimization failure) or those with very poor localization accuracy are discarded. The remaining candidates are then processed using the particle-to-trajectory assignment algorithm.

2\. Particle-to-trajectory assignments: Localized particles are processed into trajectories by creating connection hypotheses for particle assignments and finding the set of connection hypotheses that return the highest probability value. Inspired by previous approaches ([@B29]), our method begins with a greedy frame-to-frame connection phase wherein particles are assigned to short trajectories by finding the most likely set of connections between particles localized in sequential frames. We take advantage of temporal symmetry by tracking particles both forward and backward in time, forming two sets of short trajectories. Particle connections that do not exist in both sets are omitted to reduce connection biases that ordinarily result from forward-time frame-to-frame tracking methods.

Next the trajectory segments are connected over a sliding window in time, in which only connections that occur between the starts or ends of trajectories found at the center of the sliding window are kept. This approach once again results in two lists of trajectory connections, depending on whether the start or end of a short trajectory was found in the center of the sliding window. All connections that do not exist in both lists are once again removed to reduce the effect of connection bias. The processed trajectories are then scored based on the quality of their localizations. If a trajectory consists of mainly poor localizations, it will have a low score and will therefore be more likely to be removed. Any localizations that were not assigned to trajectories are discarded from the connection algorithm. Finally, the remaining trajectory segments are assigned to a global cost matrix ([@B29]) to connect the gaps between short trajectories and more accurately reconstruct the trajectories of long-lived binding events.

3\. Assignment costs: From the list of trajectories, the time a trajectory starts (birth) and the time a trajectory ends (death) are collected. The probability of a trajectory beginning or ending on a particular frame is given by a user-defined function of the minimum evidence value *e*~0~ = 0.05. The probability that two trajectories, *s*~*i*~ and *s*~*j*~, should be connected is where ∆*z* represents the particle displacement that would be measured from connecting *s*~*j*~ to *s*~*i*~. Here *M* is a user-defined probability of a missed localization in a trajectory and is only relevant when the difference in camera frame times between trajectories is greater than 1. The terms *Pl*(*s*~*i*~) and *Pl*(*s*~*j*~) represent the plausibility, defined as an upper bound of the probability, that *s*~*i*~ and *s*~*j*~, respectively, represent a true particle. Particles are connected using a diffusion with drift model. The probability of two-dimensional displacement, ∆*z* = \[∆*x*, ∆*y*\], in which the particle moves with diffusion constant *D* and drift rate **V** = \[*V*~*x*~, *V*~*y*~\], is

Here ∆*t* is the number of camera frames elapsed during the measured displacement. The values for diffusion and drift are unknown and unique for every trajectory, so a normal distribution is used for the prior on drift constants and an inverse gamma distribution is used for the prior for diffusion constants:

The hyperparameters µ~*x*~, µ~*y*~, and γ define the prior on drift velocities, and the hyperparameters α and β define the prior on diffusion constants. The probability of a displacement is where *Q* = 2∆*t*(1 + γ∆*t*).

The diffusion with drift hyperparameters are defined independently for each trajectory. Initially, a track uses default values, but as localizations are added, the values are updated, using the new information present in the additional displacement. If a trajectory's motion changes over time, the hyperparameters are relaxed toward their default values to prevent overfitting.

The plausibility terms are calculated as where *H*~0~ represents the hypothesis that a localization was generated from a uniform background. The hypothesis *H*~1~ assumes the localization was generated by the usual Gaussian-shaped point-spread function. The hyperpriors on *H*~0~, α, and β, are the same values used for estimating the background, *B*. For each subregion *H*~0~ is evaluated in, there are *N* pixels with *k* photon counts per pixel with a mean pixel count *Q*.

4\. Trajectory filtering: Given a set of associated particles, the probability that a trajectory is valid, *H*~1~, as opposed to invalid, *H*~0~, is

where *S* represents the vector of localizations associated to the trajectory under evaluation.

Off-rate parameter estimation
-----------------------------

Observed trajectories of Syk^mNG^ at the plasma membrane represent individual molecules of Syk bound to FcεRI complexes. The simplest model that describes the unbinding of Syk from FcεRI: implies that for a Syk ⋅ FcεRI, the time until dissociation is described by random variable τ\~Exp(*k*^ −^). The exponential distribution has the *memoryless property*, whereby, if τ\~Exp(*k*^ −^), then *p*(τ = *t*) = p(τ = *t* + *t*~0~ \| τ \> *t*~0~), so that the distribution of τ, is unchanged, even if the observation begins at arbitrary time *t*~0~ \> 0 after the initial binding.

1\. *The geometric distribution:* The kinetics of [Eq. 8](#m8){ref-type="disp-formula"} imply the continuous random variable τ is exponentially distributed; however, SPT trajectories are captured at a finite frame rate *t*~*f*~, so the durations *d* \> 0 are measured in discrete units of frames. Hence the distribution of trajectory durations in frames is described by a geometric distribution, *d*\~Geo(*p*^ −^). The geometric distribution is the discrete analogue of the exponential, and the only discrete distribution with the memoryless property. The geometric distribution describes the number of trials until success for a repeated Bernoulli experiment with success probability 0 \< *p*^--^ \< 1 (e.g., the number of flips required to get heads using a *p*-weighted coin). In our context, a success represents unbinding, which occurs with equal probability *p*^ −^ each frame. Thus a trajectory is like a sequence of repeated coin flips, and the duration of a trajectory in frames represents the number of flips necessary to achieve success (unbinding). We can convert between *p*^ −^ and *k*^ −^ by taking advantage of the memoryless property of the exponential distribution. During any frame \[*t*,*t* + *t*~*f*~), the probability of dissociation is independent of *t*:

Hence, the conversions are

2\. *Mixtures of geometric distributions:* If the true kinetics of Syk unbinding is described by [Eq. 8](#m8){ref-type="disp-formula"}, then we should expect the durations to follow a single geometric distribution:

The single-component geometric model is, however, a very simple model, and often more complicated models are necessary to adequately explain duration distributions. A chemically plausible extension assumes that there are different populations of bound Syk⋅ FcεRI constructs that undergo dissociation with different rates: where . The proportion of Syk ⋅ FcεRI constructs in states 1 and 2 are represented by α~1~, α~2~ ∈ (0,1), with α~1~ + α~2~ = 1. For the kinetic system of [Eq. 11](#m11){ref-type="disp-formula"}, the duration of a trajectory in frames is given by a two-component mixture of geometric distributions:

Extensions to *M* = 3 or more component geometric distributions are straightforward, where

3\. *Bayesian inference for geometric mixture models:* Using the geometric mixture models ([Eq. 13](#m13){ref-type="disp-formula"}), there are two general classes of procedures we can perform: parameter estimation and model selection. In *parameter estimation*, we assume a model for the data *d*~*i*~\~Geo~*M*~(θ) and estimate the most likely parameters θ for that model given the observed data **D**. In *Model-selection results*, we compare two or more models to determine which model best describes the observed data, after which parameter estimation can be performed on the most likely model. For both types of procedures, we use the Bayesian approach ([@B45]).

The Bayesian approach to parameter estimation begins with an application of Bayes' rule to the likelihood for model *M*,

The posterior probability distribution *P*~*M*~(θ \| **D**) is the ultimate mathematical objective of Bayesian parameter estimation. It represents the distribution of the true parameters θ given the data **D**. We can compute the posterior using [Eq. 14](#m14){ref-type="disp-formula"} to combine the *likelihood* *P*~*M*~(**D** \| θ) and the prior *P*~*M*~(θ). The *marginal likelihood* *P*~*M*~(**D**), is simply a normalization constant that we will avoid computing in our MCMC approach.

3.A. *The likelihood function:* For the *M*-component geometric mixture distribution ([Eq. 13](#m13){ref-type="disp-formula"}), the free parameters are , and the likelihood of an individual trajectory duration is

Using [Eq. 15](#m15){ref-type="disp-formula"}, we define the log-likelihood function, parametrized on θ, assuming a fixed data set **D** = *d*~1:*N*~ of *N* independent trajectories:

Note that the constraints on α imply that α~*M*~ is not free. Given α~1:*M*−1~, α~*M*~ has the fixed value , and so we treat models as parameterized on α~1:*M*−1~.

3.B. *Priors:* To ensure our inferences are solely based on the data at hand, we assume no prior information on our parameters and use a uniform prior over (0,1) for each α~*i*~ and the Jeffrey's prior ([@B45]) for dissociation probabilities:

3.C. *Extending models to multiple conditions:* To compare kinetic parameters across different experimental conditions, we can build a joint model over *K* \> 1 conditions, where the data , and each is a collection of the *N*~*K*~ \> 0 observed trajectories from experimental condition *k*. A joint *K*-condition *M*-component geometric mixture model, , has *K*(2*M* − 1) free parameters after accounting for the constraints on α fractions: and the joint-likelihood function is

Furthermore, we can investigate restrictions of the *K*-condition *M*-component model by assuming all of the *K* conditions share one or more of the underlying rate or fraction parameters. For example, if there is reason to believe all conditions share the same fast rate but may have different values for the slower rate, we can create a model where for each *k*, yet each condition retains its own and rates, so that we are left with a (*K*(2*M* − 2) + 1)--dimension model with parameters:

Similar restricted *K*-component models can be proposed by fixing any of the α or *p* parameters across the conditions.

4\. *Bayesian parameter estimation using Markov chain Monte Carlo:* Given a model *M* and data **D**, [Eq. 14](#m14){ref-type="disp-formula"} shows the posterior probability of the parameters θ given the data are proportional to the likelihood times the prior:

The Markov chain Monte Carlo method (MCMC) ([@B45]) can be used to sample from the posterior distribution using the unnormalized formula of [Eq. 21](#m21){ref-type="disp-formula"}. This requires only computing the likelihood ([Eq. 19](#m19){ref-type="disp-formula"}) and the prior ([Eq. 17](#m17){ref-type="disp-formula"}) and does not require the marginal likelihood *P*(D).

To perform parameter inference on the models, we implemented an MCMC sampler for the parameter space of the general *K*-condition *M*-component geometric model ([Eq. 18](#m18){ref-type="disp-formula"}) and the related restricted models (e.g., [Eq. 20](#m20){ref-type="disp-formula"}). We use a one-dimensional Gaussian random-walk proposal algorithm that changes a single dimension at each MC iteration, cycling through all parameters in sequence. Because all variables are constrained to the interval (0,1), we used a one-dimensional proposal Gaussian with σ = 0.05 to achieve adequate acceptance rates and mixing speed. Any proposal that was nonfeasible because of violation of constraints ([Eq. 13](#m13){ref-type="disp-formula"}) was treated as a normal rejection step. This is equivalent to assigning zero likelihood to infeasible points. In general for MCMC runs, we collect *S* = 10^6^ samples after rejecting the first *S*/4 samples as a burn-in.

If the true parameters are θ\*, the estimated that minimizes the Euclidean distance is the posterior mean, otherwise known as the minimum mean squared error estimator. The MCMC samples allow us to easily estimate the posterior mean and covariance with the sample mean and covariance. Indeed, nearly any probabilistic query or hypothesis that can be formulated about the posterior distribution can be estimated directly using the MCMC samples. Specifically, using this posterior distribution, we can calculate a posterior central interval containing 68.2% of the probability mass (termed 68% credible interval), or 1 SE given a normal distribution, to report our level of confidence for all estimated parameters .

5\. *Bayesian model selection using MCMC:* Given data set **D**, and a set of *J* \> 1 models *M*~1:*J*~, we can use Bayesian model selection to estimate the posterior probability of each model given the data *P*(*M*~*i*~ \| **D**). Bayes' rule shows that

We assume a uniform prior over models *P*(*M*~*i*~) = 1/*J*. To estimate the posterior distribution for the models with [Eq. 22](#m22){ref-type="disp-formula"}, we need to estimate the model evidence:

We use a Laplacian approximation ([@B70]) to estimate the value of the integral in [Eq. 23](#m23){ref-type="disp-formula"}, where the sample mean and covariance from an MCMC run are used to form a Gaussian approximation of the integrand. We select the model with the highest posterior probabilty, which is the MAP model estimate

As a consequence of the MCMC sampling to estimate Eq. 22, after finding *M*~MAP~ we already have the MCMC sample of the parameter posterior P(θ \| *M*~MAP~).

6\. *Conditional likelihood for data with a minimum track-length cutoff:* Very short trajectories are sometimes false positives that result from spurious localizations or tracking artifacts. Longer trajectories tend to be less susceptible to such noise. Therefore we imposed a lower bound *m* ≥ 4 on track lengths that are used in rate model inferences. Given data set **D** = *d*~1:*N*~, we know a priori that *d*~*i*~ ≥ *m*, so we replace in the likelihood function of [Eq. 16](#m16){ref-type="disp-formula"} with the conditional probability

where, for *k* ∈ **N**,

In the single-component case (*M* = 1), the geometric model has the unique memoryless property, which allows the simplification , but for *M* = 2 or more component mixture models, the memoryless property does not hold, and [Eq. 25](#m25){ref-type="disp-formula"} must be used for minimum track length--thresholded data sets.

Model-selection results
-----------------------

We used Bayesian inference methods to answer several questions about the kinetic behavior of Syk^mNG^ across different DNP-BSA doses and between Syk^mNG^ isoforms (Syk^mNG^-WT, Syk^mNG^-Y130E, and Syk^mNG^-Y130F).

First, we compared *M* = 1, *M* = 2, and *M* = 3 component models for each condition independently. For all conditions (except with dasatinib treatment), we found that the *M* = 2 model had a higher posterior probability compared with the *M* = 1 model, indicating that our data are clearly not well described by a single geometric distribution (Supplemental Figure S4C, left). While we did find that, for some conditions (high antigen doses for Syk^mNG^-WT and Syk^mNG^-Y130F), an *M* = 3 component model had a higher posterior probability, the relative improvement in the fit (Supplemental Figure S4C, right vs. center) could not justify the additional complexity it added when considering cross-condition model comparisons, given the available number of trajectories. For the *M* = 2 component model, corresponds to the faster dissociation rate *k~f~*, and to the slower rate *k~s~*. We found that parameter estimates for *k~f~* were similar across conditions when fitted independently, while α~s~ and *k~s~* varied over a wide range. We assume *k~f~* represents nonspecific binding events that we do not expect to vary across conditions.

Assuming the two-component model with a *k~f~* shared across conditions, we next asked whether there was evidence to support a model in which the slow rate *k~s~* is also shared. We compared a model in which a single *k~s~* was constrained to be shared across conditions with a model in which each condition had an independent *k~s~* rate. Across antigen-dosage conditions, we found a significantly higher posterior probability for a model in which both *k~f~* and *k~s~* are shared and only α~s~ changes per condition. In contrast, across cell-line conditions, comparing Syk^mNG^-Y130E to either Syk^mNG^-WT or Syk^mNG^-Y130F, we found a significantly higher posterior probability for a model where the slow rate *k~s~* is variable.

In addition, we use the MCMC samples from the posterior distribution (Supplemental Figure S4D) to investigate the difference between the slow kinetic rates *k~s~* across different conditions. In Supplemental Figure S4E, we plot the cumulative probability distribution for differences based on MCMC sample of the posterior of the geometric parameters and after conversion to kinetic rates ([Eq. 9](#m9){ref-type="disp-formula"}). These results show, the difference between *k~s~* values for WT and Y130F are almost certainly less than 0.1 s^−1^ and for WT versus Y130E almost certainly greater than 0.1 s^−1^ (Supplemental Figure S4E).

Single-molecule Syk^mNG^ binding simulations
--------------------------------------------

For verification of our analysis, Syk^mNG^ data were simulated using three populations of simulated emitters. The first population of emitters represented the background fluorescence described by a wide PSF sigma of 4 pixels and a fast diffusion constant of 5 pixels^2^/frame. The other two populations represented Syk^mNG^ molecules with a PSF sigma of 1 pixel and a diffusion constant of 0 pixels^2^/frame or 0.5 pixels^2^/frame, matching our experimental observation. Simulation off-rates for each population corresponded to the fit *k~f~* or *k~s~* values from our results (Supplemental Table S1). An exponential rate was also used to draw the starting time for each emitter, reflective of the α~f~ and α~s~ parameter. A set number of emitters was drawn for each population at the beginning of the simulation. All emitters were simulated with photon emission times drawn from a model with a mean photon rate per frame matching our experimental observations. An emitter was allowed to diffuse freely up until the time of photon emission, at which point the location of the captured photon was recorded as a random displacement from the actual emitter location drawn from a normal distribution scaled by the corresponding PSF sigma of the emitter. All photon locations were summed to create a Poisson-corrupted image series of emitter dynamics that was evaluated using our tracking and track lifetime analysis. Binding parameters (*k~f~*,*k~s~*,α~s~) found from analyzing these simulations were all within 1 SE of the input parameters (Supplemental Figure S4F).
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